The article discusses the study using a simple risk model comprising of three factors prior stroke, insulin-treated diabetes, and plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels to predict stroke in patients with Heart Failure with Reduced Ejection Fraction (HFrEF) without atrial fibrillation (AF). It mentions that the patients were divided into group of five based on stroke risk score.